Sterility
19
1
1
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
32%
6 trials in Phase 3/4
0%
0 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (19)
Real-world Evidence on Follitropin Delta Individual Dosing
The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies
Myo-Inositol- Based Co-treatment in Women With PCOS Undergoing Assisted Reproductive Technology
Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure
Oral Versus Vaginal Progesterone in the Luteal Support in Cryo-warmed Embryo Transfer Cycles
Embryo Implantation After Induced Endometrial Injury
HyFoSy Versus HSG as a Diagnostic Technique for Tubal Patency.
Effectiveness of Nasal Endoscope Sterilization Using a Novel Rig-S™ Device
To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment
Embryotransfer Operator and Pregnancy Rate
Endometrial Priming for Embryo Transfer
Benefits of Hysteroscopy Prior to Performing a Cycle of in Vitro Fertilization/Intracytoplasmic Sperm Injection
A Lifestyle Intervention to Improve in Vitro Fertilization Results
Efficacy of Ovarian Stimulation Based on FSHR Genotype Status
Chlamidia Antibodies Test for Tubal Factor Screening
Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
Assessment of the Therapeutic Utility of hMG-HP
Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP